Adrian J. Haigh's most recent trade in Fennec Pharmaceuticals Inc was a trade of 50,000 Stock Option done . Disclosure was reported to the exchange on May 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 50,000 | 410,246 | - | - | Stock Option | |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 25,000 | 435,246 | - | - | Restricted Shste Unit | |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 22,223 | 360,246 | - | - | Option | |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 9.32 per share. | 19 Apr 2024 | 22,223 | 0 (0%) | 0% | 9.3 | 207,029 | Common Shares |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.31 per share. | 19 Apr 2024 | 22,223 | 22,223 (0%) | 0% | 2.3 | 51,335 | Common Shares |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.31 per share. | 19 Apr 2024 | 22,222 | 22,222 (0%) | 0% | 2.3 | 51,333 | Common Shares |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 22,222 | 382,469 | - | - | Option | |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 9.33 per share. | 19 Apr 2024 | 22,222 | 0 (0%) | 0% | 9.3 | 207,442 | Common Shares |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 17 Apr 2024 | 22,222 | 22,222 (0%) | 0% | 2.3 | 51,333 | Common Shares |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2024 | 22,222 | 426,913 | - | - | Common Shares | |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2024 | 22,222 | 449,135 | - | - | Common Shares | |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 9.62 per share. | 17 Apr 2024 | 22,222 | 0 (0%) | 0% | 9.6 | 213,776 | Common Shares |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 9.91 per share. | 17 Apr 2024 | 22,222 | 22,222 (0%) | 0% | 9.9 | 220,220 | Common Shares |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 17 Apr 2024 | 22,222 | 44,444 (0%) | 0% | 2.3 | 51,333 | Common Shares |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.31 per share. | 17 Apr 2024 | 22,222 | 44,444 (0%) | 0% | 2.3 | 51,333 | Common Shares |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.31 per share. | 17 Apr 2024 | 22,222 | 22,222 (0%) | 0% | 2.3 | 51,333 | Common Shares |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 10.28 per share. | 15 Apr 2024 | 22,222 | 0 (0%) | 0% | 10.3 | 228,389 | Common Shares |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 10.30 per share. | 15 Apr 2024 | 22,222 | 22,222 (0%) | 0% | 10.3 | 228,793 | Common Shares |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 15 Apr 2024 | 22,222 | 44,444 (0%) | 0% | 2.3 | 51,333 | Common Shares |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 15 Apr 2024 | 22,222 | 22,222 (0%) | 0% | 2.3 | 51,333 | Common Shares |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 22,222 | 449,135 | - | - | Common Shares | |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 22,222 | 471,357 | - | - | Common Shares | |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.31 per share. | 15 Apr 2024 | 22,222 | 44,444 (0%) | 0% | 2.3 | 51,333 | Common Shares |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.31 per share. | 15 Apr 2024 | 22,222 | 22,222 (0%) | 0% | 2.3 | 51,333 | Common Shares |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2023 | 200,000 | 493,579 | - | - | Stock Option | |
| Fennec Pharmaceuticals Inc | Adrian J. Haigh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 20,000 | 293 | - | - | Stock Option |